Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 22,541 | 1,097 | 15,498 | 17,819 | 528 |
| TOTAL | $22,541 | $1,097 | $15,498 | $17,819 | $528 |
| Non-Current Assets | |||||
| Investments And Advances | 60,091 | 55,601 | 47,157 | 0 | 39,352 |
| Other Non-Current Assets | 92 | 109 | 106 | 41,066 | 140 |
| TOTAL | $60,183 | $55,710 | $47,263 | $41,066 | $39,492 |
| Total Assets | $82,724 | $56,807 | $62,761 | $58,885 | $40,020 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 291 | 429 | 557 | 686 | 893 |
| Accounts payable and accrued liabilities | 3,823 | 2,789 | 1,881 | 3,286 | 2,023 |
| Accrued Expenses | 4,510 | 4,071 | 4,075 | 4,272 | 5,127 |
| TOTAL | $8,624 | $7,289 | $6,513 | $8,244 | $8,043 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,309 | 2,357 | 2,064 | 1,674 | 1,389 |
| TOTAL | $35,872 | $30,067 | $24,223 | $25,445 | $16,341 |
| Total Liabilities | $44,496 | $37,356 | $30,736 | $33,689 | $24,384 |
| Shareholders' Equity | |||||
| Common Shares | 357 | 354 | 353 | 350 | 174 |
| Other shareholders' equity | -1,400 | -1,271 | -653 | 0 | 0 |
| TOTAL | $87,536 | $87,186 | $87,724 | $88,078 | $83,686 |
| Total Liabilities And Equity | $132,032 | $124,542 | $118,460 | $121,767 | $108,070 |